Last $0.03 USD
Change Today -0.0015 / -4.62%
Volume 222.3K
KBLB On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

kraig biocraft laboratories (KBLB) Key Developments

Kraig Biocraft Laboratories, Inc. Appoints Jonathan R. Rice as Chief Operating Officer

On January 20, 2015, the board of directors of Kraig Biocraft Laboratories, Inc. appointed Mr. Jonathan R. Rice as its Chief Operating Officer. Jonathan R. Rice had worked at Ultra Electronics, Adaptive Materials Inc. At UEA, he worked as the Director of Advanced Technologies since 2002, where he was responsible for new products development and commercialization. He was also the Corporate Facility Security Officer for UEA since 2006, where Mr. Rice ensured UEA's compliance with federal regulations under the National Industrial Security Program Operating Manual and completed its annual security audit. During 2004 through 2007 while working as an Engineering Manager at UEA, Mr. Rice, among other things, led the design and development of multiple fuel cell and power management systems, established a team to identify and eliminate production and performance limitation, authored technical progress and final reports for customers and provided training to military personnel on use of fuel cell systems. Mr. Rice is currently studying for his Masters of Business Administration at Michigan State University and expects to graduate in 2016.

Kraig Biocraft Laboratories Announces Creation of Monster Silk Knit in Collaboration with Warwick Mills

Kraig Biocraft Laboratories reported the creation of the textile with its genetically engineered spider silk, Monster Silk. The company added that the textile was created in partnership with Warwick Mills. With the creation of the first Monster Silk knits, Kraig has established that its genetically engineered spider silk works well with existing manufacturing methods.

Kraig Biocraft Laboratories Announces Testing of its Big Red Genetically Engineered Spider Silk

Kraig Biocraft Laboratories, Inc. announced that the company received its fiber testing equipment, including customized components, to test its new genetically engineered prototype fiber, Big Red(TM). The company announced that it created Big Red(TM), a new genetically engineered silk fiber, last fall, by using spider silk gene sequences. Preliminary testing indicated that Big Red(TM) might have properties of strength and flexibility that could have potential commercial applications. The company ordered testing equipment to verify the preliminary results and, after taking delivery, had the equipment customized to account for the unique nature of recombinant spider silk based fibers. The company intends to use the testing equipment to increase the laboratory's research and development effectiveness by providing researchers with more rapid feedback on the results of their work. The ability to quickly gather and analyze data is expected to greatly improve the effectiveness of the Company's ongoing work in artificial selection of various strains of transgenic silkworms and potentially reduce the commercialization timeline for future fibers.

Kraig Biocraft Laboratories, Inc. announced delayed annual 10-K filing

On 04/01/2014, Kraig Biocraft Laboratories, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.

Kraig Biocraft Laboratories, Inc. Amends Articles of Incorporation

Effective December 17, 2013, Kraig Biocraft Laboratories, Inc. amended its Articles of Incorporation to designate Series A of the Company's preferred stock, no par value. Under the amendment, there are two shares of Series A preferred stock authorized. The holder of each share of the Series A preferred stock is entitled to vote together with the holders of the Company's common stock on all matters upon which the Company's stockholders may vote. Each share of Series A preferred stock is entitled to 200,000,000 votes on all such matters. Each share of Series A Preferred Stock is convertible into one share of the Company's common stock at the holder's option.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
KBLB:US $0.03 USD -0.0015

KBLB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for KBLB.
View Industry Companies
 

Industry Analysis

KBLB

Industry Average

Valuation KBLB Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KRAIG BIOCRAFT LABORATORIES, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.